CASTLE BIOSCIENCES INC (CSTL)
Services-Medical Laboratories
Latest Price
$28.00
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
15.44
P/B Ratio
1.81
Valuation metrics
adjust assumptions →Base FCF: $32M (median of recent 5yr)
Growth: -15%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$14.40
49% downside
Institutional Ownership
86.8% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 2.98M | $73.0M | 9.85% | -122.3K | 2026-03-31 |
| RTW INVESTMENTS, LP | 2.76M | $67.0M | 9.10% | +643.1K | 2026-03-31 |
| PRINCIPAL FINANCIAL GROUP INC | 1.77M | $43.0M | 5.84% | -37.8K | 2026-03-31 |
| Portolan Capital Management, LLC | 1.35M | $33.0M | 4.46% | -379.2K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.18M | $28.0M | 3.89% | -- | 2026-03-31 |
| DIMENSIONAL FUND ADVISORS LP | 1.04M | $25.0M | 3.43% | -104.0K | 2026-03-31 |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 940.7K | $23.0M | 3.10% | -118.0K | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 861.8K | $21.0M | 2.84% | -- | 2026-03-31 |
| Allianz Asset Management GmbH | 811.3K | $19.0M | 2.68% | +189.0K | 2026-03-31 |
| STATE STREET CORP | 769.1K | $18.0M | 2.54% | +32.6K | 2026-03-31 |